Welcome to LookChem.com Sign In|Join Free
  • or
2-Methyl-3-phenyl-propylamine, commonly known as amphetamine, is a psychoactive stimulant and a substituted phenethylamine. It is characterized by its ability to increase alertness, energy, attention, and mood, as well as providing a euphoric high when used recreationally. As a potent central nervous system stimulant, amphetamine works by elevating the levels of certain neurotransmitters, particularly dopamine and norepinephrine, in the brain, which contributes to its stimulating and mood-enhancing effects.

77916-78-0

Post Buying Request

77916-78-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

77916-78-0 Usage

Uses

Used in Pharmaceutical Industry:
2-Methyl-3-phenyl-propylamine is used as a therapeutic agent for the treatment of attention-deficit hyperactivity disorder (ADHD), narcolepsy, and obesity. Its stimulant properties help improve focus, alertness, and energy levels in individuals with these conditions, enhancing their overall quality of life.
Used in Recreational Settings:
Although not recommended due to its potential for abuse and dependence, 2-Methyl-3-phenyl-propylamine is sometimes used recreationally for its euphoric effects. It can provide a temporary sense of increased energy, alertness, and mood enhancement.
Used in Research:
2-Methyl-3-phenyl-propylamine is also utilized in scientific research to study the effects of psychoactive substances on the central nervous system and neurotransmitter levels. This helps in understanding the mechanisms of action and potential therapeutic applications of similar compounds.

Check Digit Verification of cas no

The CAS Registry Mumber 77916-78-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,7,9,1 and 6 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 77916-78:
(7*7)+(6*7)+(5*9)+(4*1)+(3*6)+(2*7)+(1*8)=180
180 % 10 = 0
So 77916-78-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H15N/c1-9(8-11)7-10-5-3-2-4-6-10/h2-6,9H,7-8,11H2,1H3

77916-78-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-methyl-3-phenylpropan-1-amine

1.2 Other means of identification

Product number -
Other names 2-methyl-3-phenylpropylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:77916-78-0 SDS

77916-78-0Relevant academic research and scientific papers

SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS

-

Paragraph 00295-00296, (2021/04/01)

The invention provides substituted imidazole carboxamides and related compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat a medical disorder, e.g., cancer, lysosomal storage disorder, neurodegenerative disorder, inflammatory disorder, in a patient.

Synthesis of β-Chiral Amines by Dynamic Kinetic Resolution of α-Branched Aldehydes Applying Imine Reductases

Matzel, Philipp,Wenske, Sebastian,Merdivan, Simon,Günther, Sebastian,H?hne, Matthias

, p. 4281 - 4285 (2019/08/20)

Imine reductases (IREDs) allow the one-step preparation of optically active secondary and tertiary amines by reductive amination of ketones. Until now, mainly α-chiral amines have been prepared by this route. In this study, we explored the possibility of synthesizing β-chiral amines, a class of compounds which is also frequently found as structural motif in pharmaceuticals but much more challenging to prepare due to the following reasons: (i) The aldehyde substrate already contains the chiral center and needs to be racemized to enable full conversion. (ii) Because the intermediate imine bears the stereo center two carbon atoms remote to the imine nitrogen, it is more challenging to achieve high enantioselectivity compared to α-chiral amine synthesis. For investigating the proof of concept, we first confirmed that different IREDs are able to convert a variety of α-branched aldehydes when combined with five different amine substrates. The IRED from Streptomyces ipomoeae was a suitable enzyme facilitating the dynamic kinetic resolution of 2-phenylpropanal and a substituted 2-methyl-3-phenylpropanal: the corresponding N-methylated β-chiral amines were obtained with '95 % conversion and 78 and 95 %ee. Other amines were formed with low to moderate enantiomeric excess. This exemplifies the potential of IREDs for the one-step synthesis of secondary β-chiral amines, but also the challenge to identify highly selective enzymes for a desired amine product.

Preparation of substituted enol derivatives from terminal alkynes and their synthetic utility

DeBergh, John R.,Spivey, Kathleen M.,Ready, Joseph M.

supporting information; experimental part, p. 7828 - 7829 (2009/02/01)

Stereodefined enol derivatives of aldehydes are prepared from terminal alkynes. Specifically, terminal alkynes are known to undergo Cp2ZrCl2-catalyzed methylalumination. Here, we show that the resultant vinylalanes can be oxygenated with peroxyzinc species to generate trisubstituted enolates. Electrophilic trapping with carboxylic anydrides or silyl triflates yields trisubstituted enol esters or silanes, respectively. The tandem carbometalation/oxygenation tolerates free and protected alcohols, heterocycles, olefins, and nitriles. Stereodefined enol esters can undergo asymmetric dihydroxylation to yield optically active α-hydroxy aldehydes. Reduction with NaBH4 provides the diols of 1,1-disubstituted olefins in excellent ee. An application of this methodology to the enantioselective synthesis of the insect pheromone frontalin is presented. Finally, α-hydroxy aldehydes are shown to undergo homologation to a terminal alkyne, reductive amination, oxidation and olefination. Preliminary results indicate that tandem carbometalation/amination can be accomplished with azodicarboxylates. In this way, ene-hydrazines are formed in excellent yield. Copyright

Substituted indolizine-like compounds and methods of use

-

, (2008/06/13)

Selected novel substituted indolizine-like compounds are effective for treatment of diseases, such as TNF-α, IL-1β, IL-6 and/or IL-8 mediated diseases, and other maladies, such as cancer, pain and diabetes. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for treatment of diseases and other maladies or conditions involving inflammation, cancer, pain, diabetes and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Substituted pyridine and pyridazine compounds and methods of use

-

, (2008/06/13)

Selected novel substituted pyridine and pyridazine compounds are effective for prophylaxis and treatment of diseases, such as TNF-α, IL-1β, IL-6 and/or IL-8 mediated diseases, and other maladies, such as cancer, pain and diabetes. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving inflammation, cancer, pain, diabetes and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Substituted pyrimidinone and pyridone compounds and methods of use

-

, (2008/06/13)

Selected novel substituted pyrimidinone and pyridone compounds are effective for prophylaxis and treatment of diseases, such as TNF- alpha , IL-1 beta , IL-6 and/or IL-8 mediated diseases, and other maladies, such as pain and diabetes. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving inflammation, pain, diabetes and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

A USEFUL APPROACH TO PRIMARY AMINES

Belletire, J. L.,Fry, D. F.

, p. 29 - 36 (2007/10/02)

Smooth reduction of acylsulfonamides to sulfonamides by borane, when coupled to standard sulfonamide cleavage procedures, provides a general route to primary amines.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 77916-78-0